PC
BIIB icon

Palo Capital’s Biogen BIIB Stock Holding History

Palo Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,428
Closed -$1.55M – 142
2016
Q2 		$1.55M Buy
6,428
+4,072
+173% +$1.07M 0.53% 66
2016
Q1 		$613K Sell
2,356
-764
-24% -$202K 0.48% 75
2015
Q4 		$956K Buy
+3,120
New +$897K 0.87% 52
2015
Q3 		– Sell
-2,202
Closed -$877K – 134
2015
Q2 		$877K Buy
+2,202
New +$884K 0.69% 73

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Palo Capital's BIIB Position: Q3 2016 in Review

Palo Capital sold out of Biogen (BIIB) in Q3 2016, closing a stake of 6,428 shares — an estimated $1.55M sold.

Palo Capital first reported a position in BIIB in Q2 2015 and held it in 4 quarters. The position peaked at $1.55M in Q2 2016. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Palo Capital reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
  • Palo Capital sold 6,428 Biogen shares in Q3 2016, an estimated $1.55M.
  • Palo Capital first reported a position in Biogen in Q2 2015 and held it in 4 quarters.
  • Palo Capital's Biogen position peaked at $1.55M in Q2 2016.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Palo Capital's 13F filing for Q3 2016, filed 20 Oct 2016.